403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Mutares Has Acquired Ameriterpenes LLC, The US Terpene Ingredients Business Of Symrise
|
Mutares SE & Co. KGaA
/ Key word(s): Takeover/Agreement
Mutares has acquired AmeriTerpenes LLC, the US Terpene Ingredients business of Symrise 01.09.2026 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Mutares has acquired AmeriTerpenes LLC , the US Terpene Ingredients business of Symrise
For more information, please contact: Mutares SE & Co. KGaA Investor Relations Phone: +49 89 9292 7760 Email: ... Press Contact in Germany CROSS ALLIANCE communication GmbH Susan Hoffmeister Phone: +49 89 125 09 0333 Email: ... Press Contact in France VAE SOLIS COMMUNICATIONS Marie-Caroline Garnier Phone: +33 6 22 86 39 17 Email: ... Press Contact in UK & US 14:46 Consulting Tom Sutton Phone: +44 7796 474940 Email: 01.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Mutares SE & Co. KGaA |
| Arnulfstr.19 | |
| 80335 Munich | |
| Germany | |
| Phone: | +49 (0)89-9292 776-0 |
| Fax: | +49 (0)89-9292 776-22 |
| E-mail: | ... |
| Internet: | |
| ISIN: | DE000A2NB650 |
| WKN: | A2NB65 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 391200NWMO6NLQFSCU64 |
| EQS News ID: | 2389974 |
| End of News | EQS News Service |
2389974 01.09.2026 CET/CEST
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment